(2R,3R,4R,5R)-3,4-Dihydroxy-N,N′-bis[(2S)-3-methyl-1-(methylamino)-1-oxo-2-butanyl]-2,5-bis{[4-(2-pyridinyl)benzyl]oxy}hexanediamide

(2R,3R,4R,5R)-3,4-Dihydroxy-N,N′-bis[(2S)-3-methyl-1-(methylamino)-1-oxo-2-butanyl]-2,5-bis{[4-(2-pyridinyl)benzyl]oxy}hexandiamid

(2R,3R,4R,5R)-3,4-Dihydroxy-N,N′-bis[(2S)-3-methyl-1-(methylamino)-1-oxo-2-butanyl]-2,5-bis{[4-(2-pyridinyl)benzyl]oxy}hexanediamide

(2R,3R,4R,5R)-3,4-Dihydroxy-N,N′-bis[(2S)-3-méthyl-1-(méthylamino)-1-oxo-2-butanyl]-2,5-bis{[4-(2-pyridinyl)benzyl]oxy}hexanediamide

(2R,3R,4R,5R)-3,4-dihydroxy-N,N′-bis[(2S)-3-methyl-1-(methylamino)-1-oxobutan-2-yl]-2,5-bis{[4-(pyridin-2-yl)benzyl]oxy}hexanediamide (non-preferred name)

3,4-Dihydroxy-2,5-bis-(4-pyridin-2-yl-benzyloxy)-hexanedioic acid bis-[(2-methyl-1-methylcarbamoyl-propyl)-amide]

C2-Symmetric inhibitor 10

Dimer of Gag-Pol polyprotein [501-599]

Gag-Pol polyprotein

N1,N6-bis[(1S)-2-Methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis[4-(2-pyridyl)benzyloxy]-3,4-dihydroxyhexanediamide

POL_HV1BR